APLN and breast cancer: Our experimental models using E0771 mammary tumor cells, NeuT oncogene‐driven spontaneous mammary cancer, as well as clonal induction of oncogenic KRas to trigger lung cancer, clearly demonstrate that loss of Apelin alone markedly reduces tumor angiogenesis, impairs tumor growth, and as a consequence improves survival of these animals.